Argonne National Laboratory

World’s X-ray facilities team up to battle COVID-19

8-May-2020 3:05 PM EDT, by Argonne National Laboratory

Newswise — Leaders from the world’s best X-ray facilities, including Argonne’s Advanced Photon Source, have developed a strategy for cooperatively combating COVID-19.

The best and brightest X-ray science facilities in the world are working together to help in the fight against the COVID-19 pandemic. Numbered among them is the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory.

In April, leadership of the world’s X-ray science facilities, including APS Director Stephen Streiffer, convened for a virtual summit. Below is the action plan developed at this summit, outlining how these facilities will work together to share information about COVID-19. The APS continues to welcome research groups working to learn more about the virus that causes COVID-19 and lay the groundwork for treatments and vaccines.

COVID-19 affects all of us, and I’m proud to be working with our international colleagues as we pool our resources to combat this pandemic,” Streiffer said.

Read more on Argonne’s work to fight the coronavirus.

The COVID-19 pandemic is, more than ever, uniting scientists and the X-ray Science Facilities worldwide, in their sorrow for the loss of life and the suffering the virus has caused for the people around the world. They also express heartfelt admiration and lasting gratitude to all front-line health workers for their tireless dedication to treating the people impacted by the pandemic.

The international network of X-ray Science Facilities, composed of the X-ray Synchrotron Radiation and X-ray Free Electron Laser Facilities, is deeply engaged with overcoming the pandemic. The X-ray Science Facilities’ role is to create and implement scientific and technological research activities to effectively study, understand and contribute solutions to the COVID-19 pandemic, including new drugs, therapeutic strategies and medical equipment developments.

This engagement has already started worldwide, and many X-ray Science Facilities are carrying out research focused on the SARS-CoV-2 virus, and making available their instruments with rapid access and remote channels to scientists desiring to address specific COVID-19 research topics.

The X-ray Science Facilities gathered to align intents and strategies on ​development of alliances between universities, industry and facilities” at their first SR9 Summit, which was held in Sendai, Japan in April 2019.

The X-ray Science Facilities, with the intent to further coordinate and strengthen their support of scientific research and solutions to the COVID-19 pandemic, assembled for a remote access video SR20 Summit April 23-24. They shared their experience on facility activities in the recent weeks, and decided to develop a cooperative strategy across all facilities worldwide to work jointly to overcome the pandemic.

The X-ray Science Facilities adopted the following action plan:

  1. Share information and contribute to the coordination of efforts across all X-ray Science Facilities on scientific research addressing the COVID-19 pandemic
  2. Explore the establishment of a worldwide X-ray Science Facilities network including university and industrial users for a comprehensive mobilization of facilities
  3. Study the development of a shared IT system to accelerate the process of information distribution, favor global cooperation among facilities and enable the most rapid and effective access for scientific projects across facilities
  4. Exchange experience on remote access and sample mail-in procedures by the user community to maintain and strengthen experimental activities without user travel
  5. Coordinate efforts of the X-ray Science Facilities with those of other analytical facilities as, for example, those using neutrons, cryo-electron-microscopy, lasers and nuclear magnetic resonance

Delegates:

Prof. Dr. Hideo Ohno, President, TOHOKU University

Dr. Chi-Chang Kao, Director, SLAC National Accelerator Laboratory

Prof. Paul McIntyre, Director, SSRL

Prof. Michael Dunne, Director, LCLS

Dr. Stephen Streiffer, Director, Advanced Photon Source

Dr. Stephen Kevan, Director, Advanced Light Source

Dr. John Hill, Director, NSLS-Il

Prof. Joel Brock, Director, CHESS

Prof. Andrew Peele, Director, ANSTO Australian Synchrotron

Dr. Gwo-Hui Luo, Director, NSRRC

Dr. Tetsuya Tshikawa, Director, RIKEN SPring-8 Center

Dr. Tn Soo Ko, Director, Pohang Accelerator Laboratory

Dr. Francesco Sette, Director General, ESRF

Prof. Edgar Weckert, Research Director, DESY

Prof. Robert Feidenhans’l, Managing Director, European XFEL

Dr. Jean Daillant, Director, Soleil Laboratory

Dr. Andrew Harrison, CEO, Diamond Light Source Limited

Dr. Caterina Biscari, Director, ALBA

Prof. Gabriel Aeppli, Head Photon Science Division, Paul Scherrer Institut, ETH and EPFL

Dr. Ian McNulty, Director, Max IV

Prof. Jan Lüning, Scientific Director, BESSY II, Helmholtz-Zentrum Berlin

Dr. Claudio Masciovecchio, Director FERMI Free Electron Laser

About the Advanced Photon Source

The U. S. Department of Energy Office of Science’s Advanced Photon Source (APS) at Argonne National Laboratory is one of the world’s most productive X-ray light source facilities. The APS provides high-brightness X-ray beams to a diverse community of researchers in materials science, chemistry, condensed matter physics, the life and environmental sciences, and applied research. These X-rays are ideally suited for explorations of materials and biological structures; elemental distribution; chemical, magnetic, electronic states; and a wide range of technologically important engineering systems from batteries to fuel injector sprays, all of which are the foundations of our nation’s economic, technological, and physical well-being. Each year, more than 5,000 researchers use the APS to produce over 2,000 publications detailing impactful discoveries, and solve more vital biological protein structures than users of any other X-ray light source research facility. APS scientists and engineers innovate technology that is at the heart of advancing accelerator and light-source operations. This includes the insertion devices that produce extreme-brightness X-rays prized by researchers, lenses that focus the X-rays down to a few nanometers, instrumentation that maximizes the way the X-rays interact with samples being studied, and software that gathers and manages the massive quantity of data resulting from discovery research at the APS.

This research used resources of the Advanced Photon Source, a U.S. DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://​ener​gy​.gov/​s​c​ience.




Filters close

Showing results

110 of 2529
Newswise: Drug that calms ‘cytokine storm’ associated with 45% lower risk of dying among COVID-19 patients on ventilators
Released: 13-Jul-2020 7:25 AM EDT
Drug that calms ‘cytokine storm’ associated with 45% lower risk of dying among COVID-19 patients on ventilators
Michigan Medicine - University of Michigan

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn’t receive the drug, according to a new observational study.

10-Jul-2020 9:00 AM EDT
Long-term strategies to control COVID-19 pandemic must treat health and economy as equally important, argue researchers
University of Cambridge

Strategies for the safe reopening of low and middle-income countries (LMICs) from months of strict social distancing in response to the ongoing COVID-19 pandemic must recognise that preserving people’s health is as important as reviving the economy, argue an international team of researchers.

Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.


Showing results

110 of 2529

close
2.76179